Literature DB >> 26019385

Disseminated bronchiectasis in an adult with common variable immunodeficiency.

Andrés Felipe Zea-Vera1, Olga Lucia Agudelo-Rojas2.   

Abstract

Primary immunodeficiencies (PID) are traditionally considered childhood diseases; however, adults account for 35% of all patients with PID. Antibody deficiencies, especially Common Variable Immunodeficiency (CVID), which have their peak incidence in adulthood, require a high suspicion index. Even though the estimated frequency of CVID is not high (1:25,000), high rates of under diagnosis and under reporting are very likely. The delay in diagnosis increases the morbidity and mortality; therefore, adult physicians should be able to suspect, identify and initiate management of individuals with PID. Here we report the case of a 37 year-old man presenting to the emergency room with dyspnea, fever and cough; he developed respiratory failure requiring mechanical ventilation. He complained of recurring pneumonia associated with widespread bronchiectasis since he was 18 years old. Serum immunoglobulins quantification showed severe hypogammaglobulinemia (total IgG <140 mg/dL; total IgA, 2.9 mg/dL; and total IgM <5 mg/dL). Treatment with Human Intravenous Immunoglobulin (IVIG) 10% was started, and with antibiotic treatment for severe pneumonia (during 14 days) was also prescribed. His clinical evolution has been favorable after one year follow-up. Common Variable Immunodeficiency (CVID) diagnosis was made.

Entities:  

Keywords:  Primary immunodeficiency; bronchiectasis; common variable immunodeficiency; hypogammaglobulinemia; recurring pneumonia

Mesh:

Substances:

Year:  2015        PMID: 26019385      PMCID: PMC4437287     

Source DB:  PubMed          Journal:  Colomb Med (Cali)        ISSN: 0120-8322


  14 in total

Review 1.  Primary immunodeficiency diseases in adulthood.

Authors:  D S Riminton; S Limaye
Journal:  Intern Med J       Date:  2004-06       Impact factor: 2.048

Review 2.  The initial evaluation of adults with bronchiectasis.

Authors:  Mark L Metersky
Journal:  Clin Chest Med       Date:  2012-04-20       Impact factor: 2.878

Review 3.  How I treat common variable immune deficiency.

Authors:  Charlotte Cunningham-Rundles
Journal:  Blood       Date:  2010-03-23       Impact factor: 22.113

4.  Aetiology in adult patients with bronchiectasis.

Authors:  A Shoemark; L Ozerovitch; R Wilson
Journal:  Respir Med       Date:  2007-01-12       Impact factor: 3.415

5.  Classification of common variable immunodeficiencies using flow cytometry and a memory B-cell functionality assay.

Authors:  Amelia L Rösel; Carmen Scheibenbogen; Ulrike Schliesser; André Sollwedel; Bodo Hoffmeister; Leif Hanitsch; Horst von Bernuth; Renate Krüger; Klaus Warnatz; Hans-Dieter Volk; Sybill Thomas
Journal:  J Allergy Clin Immunol       Date:  2014-08-10       Impact factor: 10.793

Review 6.  The many faces of common variable immunodeficiency.

Authors:  Charlotte Cunningham-Rundles
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2012

Review 7.  Key aspects for successful immunoglobulin therapy of primary immunodeficiencies.

Authors:  C Cunningham-Rundles
Journal:  Clin Exp Immunol       Date:  2011-06       Impact factor: 4.330

8.  Clinical and Immunological Spectrum of Common Variable Immunodeficiency (CVID).

Authors:  Anthony David B Webster
Journal:  Iran J Allergy Asthma Immunol       Date:  2004-09       Impact factor: 1.464

9.  [Phenotypic diagnosis of primary immunodeficiencies in Antioquia, Colombia, 1994-2002].

Authors:  Carlos Julio Montoya; Julieta Henao; Helí Salgado; María M Olivares; Juan A López; Claudia Rugeles; José Luis Franco; Julio Orrego; Diana M García; Pablo J Patiño
Journal:  Biomedica       Date:  2002-12       Impact factor: 0.935

10.  Clinical picture and treatment of 2212 patients with common variable immunodeficiency.

Authors:  Benjamin Gathmann; Nizar Mahlaoui; Laurence Gérard; Eric Oksenhendler; Klaus Warnatz; Ilka Schulze; Gerhard Kindle; Taco W Kuijpers; Rachel T van Beem; David Guzman; Sarita Workman; Pere Soler-Palacín; Javier De Gracia; Torsten Witte; Reinhold E Schmidt; Jiri Litzman; Eva Hlavackova; Vojtech Thon; Michael Borte; Stephan Borte; Dinakantha Kumararatne; Conleth Feighery; Hilary Longhurst; Matthew Helbert; Anna Szaflarska; Anna Sediva; Bernd H Belohradsky; Alison Jones; Ulrich Baumann; Isabelle Meyts; Necil Kutukculer; Per Wågström; Nermeen Mouftah Galal; Joachim Roesler; Evangelia Farmaki; Natalia Zinovieva; Peter Ciznar; Efimia Papadopoulou-Alataki; Kirsten Bienemann; Sirje Velbri; Zoya Panahloo; Bodo Grimbacher
Journal:  J Allergy Clin Immunol       Date:  2014-02-28       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.